We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLNA
26
Filana Therapeutics
FLNA
$48.8M
$11.3M 0.74%
+500,000
New +$10.6M
OKLO
27
Oklo
OKLO
$7.75B
$10.8M 0.71%
+1,020,246
New +$10.6M
PLAO
28
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$8.77M 0.58%
790,006
+302,581
+62% +$3.34M
CFFS
29
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$8.68M 0.57%
800,562
+435,066
+119% +$4.68M
SLAM
30
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$8.67M 0.57%
800,000
-1,060,843
-57% -$11.5M
TRIS
31
DELISTED
Tristar Acquisition I Corp.
TRIS
$8.37M 0.55%
776,430
+277,604
+56% +$2.99M
CNDA
32
DELISTED
Concord Acquisition Corp II
CNDA
$8.36M 0.55%
805,038
+60,984
+8% +$631K
KDK
33
Kodiak AI
KDK
$865M
$7.74M 0.51%
741,727
+198,599
+37% +$2.05M
AIRJ
34
Montana Technologies Corp
AIRJ
$435M
$7.68M 0.5%
715,000
+701,399
+5,157% +$7.5M
MNTN
35
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$7.64M 0.5%
698,401
+510,718
+272% +$5.55M
TRTL
36
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$7.34M 0.48%
691,215
-783,290
-53% -$8.27M
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.27M 0.48%
+123,783
New +$6.96M
AAPL icon
38
Apple
AAPL
$4.47T
$6.45M 0.42%
33,512
-17,918
-35% -$3.31M
NFYS
39
DELISTED
Enphys Acquisition Corp.
NFYS
$6.37M 0.42%
+596,540
New +$6.32M
LL
40
DELISTED
LL Flooring Holdings, Inc.
LL
$6.33M 0.41%
1,622,000
– –
ZPTA
41
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
$6.19M 0.41%
569,389
+77,934
+16% +$842K
PHYT
42
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$6.18M 0.41%
561,368
-53,507
-9% -$586K
CURR
43
Currenc Group
CURR
$356M
$5.95M 0.39%
530,678
+390,878
+280% +$4.36M
EDR
44
DELISTED
Endeavor Group Holdings, Inc.
EDR
$5.93M 0.39%
+250,000
New +$5.64M
USAR
45
USA Rare Earth Inc
USAR
$4.72B
$5.9M 0.39%
571,538
-123,416
-18% -$1.27M
ORCL icon
46
Oracle
ORCL
$425B
$5.68M 0.37%
+53,863
New +$5.88M
HYAC
47
DELISTED
Haymaker Acquisition Corp 4
HYAC
$5.41M 0.35%
526,839
-555,276
-51% -$5.68M
KVAC
48
DELISTED
Keen Vision Acquisition Corp
KVAC
$5.31M 0.35%
514,089
-379,349
-42% -$3.9M
APCA
49
DELISTED
AP Acquisition Corp
APCA
$5.14M 0.34%
461,749
+67,690
+17% +$747K
ACET icon
50
Adicet Bio
ACET
$73.9M
$5.13M 0.34%
169,705
– –
1
2
3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.